08048035968
Afanat 40 mg Tablet UK Wholesale – Birmingham | Competitive Prices | Phoenix Exim | Trusted Exporter

1. General Information

Afanat 40 mg Tablet is an oral targeted cancer medicine containing afatinib. Afatinib belongs to a class of medicines called tyrosine kinase inhibitors (TKIs). It is prescribed mainly for adults with certain molecularly defined forms of NSCLC.

It is a prescription-only medicine and should be used under the supervision of an oncologist. The appropriate dose and treatment duration depend on the patient's cancer type, EGFR status, overall health and tolerance to treatment.

2. Product Information

  • Brand: Afanat 40 mg Tablet
  • Active ingredient: Afatinib dimaleate equivalent to 40 mg afatinib
  • Dosage form: Film-coated oral tablet
  • Therapeutic class: Anticancer / targeted therapy
  • Drug class: Tyrosine kinase inhibitor
  • Primary therapeutic area: Oncology
  • Common pack: 28 tablets, depending on the marketed presentation
  • Manufacturer/Marketer: Natco Pharma Ltd.
  • Storage: Store below 30°C and protect according to the product's packaging instructions.

3. Uses of Afanat 40 mg

Afanat 40 mg is used primarily in the treatment of non-small cell lung cancer (NSCLC) in patients whose tumors have appropriate EGFR mutations.

It may be used as first-line treatment in certain patients with metastatic NSCLC with non-resistant EGFR mutations. Afatinib is also indicated for certain patients with metastatic squamous NSCLC whose disease has progressed following platinum-based chemotherapy.

Important: EGFR mutation testing is generally required to determine whether afatinib is appropriate.

4. Benefits of Afanat 40 mg

The potential therapeutic benefits of afatinib include:

  • Provides targeted treatment for selected EGFR-mutated NSCLC.
  • Helps block abnormal growth-promoting signals in cancer cells.
  • Can be used as an oral targeted therapy rather than an injectable treatment.
  • May help control disease progression in appropriate patients.
  • Provides a treatment option for certain patients with advanced or metastatic NSCLC.

Treatment response varies from patient to patient and should be assessed by the treating oncologist.

5. Side Effects of Afanat 40 mg

Like other anticancer medicines, Afanat 40 mg can cause side effects. Important reported adverse effects include:

  • Diarrhea
  • Skin rash
  • Dry skin
  • Nausea
  • Mouth inflammation or sores
  • Reduced appetite
  • Vomiting
  • Nail-related problems
  • Eye irritation or dryness
  • Fatigue

Some adverse reactions can become serious. Persistent or severe diarrhea, significant skin reactions, breathing difficulties, eye problems or signs of liver injury should be reported promptly to the treating healthcare professional.

6. Common Side Effects

The commonly reported side effects include:

Diarrhea, acne-like or other skin rash, dry skin and nausea.

Patients should maintain adequate hydration, particularly if diarrhea occurs. The treating doctor may prescribe supportive medicines or adjust the afatinib dose when adverse effects are significant.

7. How to Use Afanat 40 mg

Afanat should be taken exactly as prescribed by the oncologist.

  • Take the tablet orally with water.
  • It is generally taken once daily.
  • Take it on an empty stomach, usually at least 1 hour before eating or at least 2 hours after a meal.
  • Try to take it at approximately the same time each day.
  • Swallow the tablet whole; do not crush or chew it unless specifically instructed.
  • Do not change the dose or discontinue treatment without consulting the oncologist.

The FDA prescribing information lists 40 mg once daily as the recommended starting dose for indicated patients, although dose adjustments may be required depending on tolerability and clinical circumstances.

8. How Afanat 40 mg Works

Afatinib is a tyrosine kinase inhibitor. It irreversibly blocks signaling through members of the ErbB receptor family, including EGFR (ErbB1), HER2 (ErbB2) and HER4 (ErbB4).

By inhibiting these signaling pathways, afatinib can interfere with signals that promote cancer-cell growth and survival.

This targeted mechanism is particularly relevant in NSCLC tumors containing certain EGFR mutations.

9. Safety Advice

  • Prescription use: Use only under qualified oncology supervision.
  • EGFR testing: Appropriate molecular testing should be performed when required to establish whether afatinib is suitable.
  • Diarrhea: Severe or persistent diarrhea can lead to dehydration and requires prompt medical attention.
  • Skin: Use appropriate sun protection because skin reactions can occur.
  • Lungs: Report new or worsening breathing difficulties immediately because serious lung inflammation is a potential adverse reaction.
  • Eyes: Report eye pain, redness, significant dryness or visual changes.
  • Liver: Patients with liver problems may require additional monitoring.
  • Kidneys: Dose adjustment may be necessary in severe renal impairment.
  • Pregnancy: Afatinib may harm an unborn baby. Discuss pregnancy prevention with the treating doctor.
  • Breastfeeding: Breastfeeding is generally not recommended during treatment.
  • Drug interactions: Inform the healthcare professional about all prescription medicines, OTC products and supplements being used.
  • Do not self-medicate: Afatinib is a potent anticancer medicine and should not be started, stopped or dose-adjusted without medical guidance.

10. Frequently Asked Questions

Q1. What is Afanat 40 mg used for?
Afanat 40 mg is primarily used for certain forms of non-small cell lung cancer, particularly NSCLC with appropriate EGFR mutations.

Q2. What is the active ingredient in Afanat 40 mg?
It contains afatinib 40 mg, supplied as afatinib dimaleate.

Q3. Is Afanat 40 mg a chemotherapy medicine?
It is an oral targeted anticancer therapy, specifically a tyrosine kinase inhibitor, rather than conventional cytotoxic chemotherapy.

Q4. How often is Afanat 40 mg taken?
For appropriate patients, the standard recommended starting dose is commonly 40 mg once daily, but the treating oncologist determines the actual regimen.

Q5. Should Afanat be taken with food?
It is generally taken on an empty stomach.

Q6. What are the most common side effects?
Diarrhea, rash, dry skin and nausea are among the most common side effects.

Q7. Can the dose be reduced?
Yes. Dose modification may be required when adverse reactions occur, but this should only be done by the treating physician.

Q8. Is Afanat 40 mg available as a generic afatinib product?
Afanat is a branded product containing afatinib. Other brands and presentations containing afatinib may also be available in different markets.

Q9. Can Afanat 40 mg be used for every type of lung cancer?
No. Its use depends on the cancer subtype and relevant molecular characteristics, including EGFR status.

Q10. Is Afanat 40 mg prescription-only?
Yes. Afatinib is a prescription anticancer medicine and should be supplied and used according to applicable regulations.

11. Substitutes for Afanat 40 mg

Substitutes should contain the same active ingredient and strength and should only be selected with medical approval.

Examples of afatinib 40 mg products/brands found in the Indian market include:

  • Afatin 40 mg
  • Afayro 40 Tablet
  • Xovoltib 40 mg

For example, current medicine listings identify Afatin 40 mg and Afayro 40 mg as products containing afatinib dimaleate 40 mg.

Note: Availability, manufacturer, registration status and approved indications can differ between countries. A substitute should therefore be verified by a licensed healthcare professional or pharmacist.

12. SEO & B2B Keywords

High-Intent Keywords

  • Afanat 40 mg Tablet
  • Afanat 40 mg exporter from India
  • Afanat 40 mg supplier India
  • Afanat 40 mg pharmaceutical exporter
  • Afatinib 40 mg Tablet exporter
  • Afatinib 40 mg supplier from India
  • Afatinib 40 mg wholesale supplier
  • Afatinib tablets B2B supplier
  • Afatinib 40 mg medicine exporter
  • Afatinib oncology medicine supplier
  • Afanat 40 mg manufacturer India
  • Afatinib 40 mg bulk supplier
  • Afanat 40 mg tablets wholesale
  • Generic Afatinib 40 mg supplier
  • Afatinib 40 mg for NSCLC

Country-Focused Keywords

  • Afanat 40 mg exporter to USA
  • Afatinib 40 mg supplier to UK
  • Afatinib 40 mg exporter to Australia
  • Afanat 40 mg supplier to Singapore
  • Afatinib 40 mg exporter to Canada
  • Afanat 40 mg supplier to South Korea
  • Afatinib 40 mg exporter to UAE
  • Afatinib medicine exporter from Nagpur India
  • Afanat 40 mg pharmaceutical supplier from Nagpur
  • Afatinib oncology medicines exporter India
Aug 12th, 2026 3:34 PM

Keywords